RecruitingNCT06491732

EIM Via the Myolex mScan as an ALS Biomarker

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Beth Israel Deaconess Medical Center
Principal Investigator
Seward Rutkove, MD
Beth Israel Deaconess Medical Center
Intervention
Electrical Impedance Myography(device)
Enrollment
80 enrolled
Eligibility
18 years · All sexes
Timeline
20252027

Study locations (6)

Collaborators

United States Department of Defense

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06491732 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials